Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Denison Mines NYSEAMERICAN:DNN$1.24 -0.06 (-4.62%) Closing price 04/3/2025 04:10 PM EasternExtended Trading$1.25 +0.01 (+0.40%) As of 05:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.11 billionP/E Ratio-124.00Consensus RatingBuyConsensus Price Target$3.00 (+141.9% Upside)Volume61.92 million sharesAverage Volume26.54 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Stardust Power NASDAQ:SDST$0.50 -0.03 (-5.84%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.51 +0.00 (+0.79%) As of 06:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$26.66 millionConsensus RatingBuyConsensus Price Target$5.11 (+912.4% Upside)Volume208,491 sharesAverage Volume359,296 sharesToday's Range$0.48▼$0.543. OS Therapies NYSE:OSTX$1.54 +0.03 (+1.99%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.60 +0.06 (+3.96%) As of 06:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS TherapiesMarket Capitalization$33.52 millionConsensus RatingBuyConsensus Price Target$18.00 (+1,068.8% Upside)Volume357,045 sharesAverage Volume506,543 sharesToday's Range$1.46▼$1.804. enCore Energy NASDAQ:EU$1.18 -0.09 (-7.09%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.23 +0.05 (+4.24%) As of 05:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$236.71 millionP/E Ratio-4.21Consensus RatingBuyConsensus Price Target$4.38 (+270.8% Upside)Volume2.97 million sharesAverage Volume1.44 million shares5. Quince Therapeutics NASDAQ:QNCX$1.26 -0.06 (-4.55%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.22 -0.04 (-3.57%) As of 04/3/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$55.44 millionP/E Ratio-1.02Consensus RatingBuyConsensus Price Target$8.00 (+534.9% Upside)Volume130,882 sharesAverage Volume244,626 shares6. GeoVax Labs NASDAQ:GOVX$1.10 -0.08 (-6.78%) As of 04/3/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$11.14 millionP/E Ratio-0.19Consensus RatingBuyConsensus Price Target$14.20 (+1,190.9% Upside)Volume436,895 sharesAverage Volume611,722 sharesRemove Ads7. Cardiol Therapeutics NASDAQ:CRDL$0.91 -0.01 (-1.09%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.93 +0.02 (+1.76%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$75.17 millionP/E Ratio-2.33Consensus RatingBuyConsensus Price Target$8.40 (+823.1% Upside)Volume205,795 sharesAverage Volume383,791 shares8. Reviva Pharmaceuticals NASDAQ:RVPH$0.56 +0.00 (+0.63%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.56 +0.00 (+0.09%) As of 05:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$18.84 millionP/E Ratio-0.51Consensus RatingBuyConsensus Price Target$10.00 (+1,674.6% Upside)Volume806,140 sharesAverage Volume1.09 million shares9. Rezolve AI NASDAQ:RZLV$1.45 +0.06 (+4.32%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.69%) As of 06:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$249.67 millionConsensus RatingBuyConsensus Price Target$6.00 (+313.8% Upside)Volume2.95 million sharesAverage Volume5.17 million sharesToday's Range$1.27▼$1.4910. Nkarta NASDAQ:NKTX$1.71 -0.20 (-10.47%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.72 +0.02 (+0.88%) As of 05:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$135.53 millionP/E Ratio-0.91Consensus RatingBuyConsensus Price Target$14.86 (+768.8% Upside)Volume1.09 million sharesAverage Volume1.09 million shares11. Immunic NASDAQ:IMUX$1.05 -0.06 (-5.41%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.02 -0.03 (-2.38%) As of 06:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$100.07 millionP/E Ratio-0.85Consensus RatingBuyConsensus Price Target$12.67 (+1,106.3% Upside)Volume844,011 sharesAverage Volume609,551 sharesRemove Ads12. Western Copper & Gold NYSE:WRN$1.08 -0.02 (-1.82%) As of 04/3/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$220 millionP/E Ratio-54.00Consensus RatingBuyConsensus Price Target$4.25 (+293.5% Upside)Volume376,655 sharesAverage Volume295,653 shares13. PMV Pharmaceuticals NASDAQ:PMVP$1.00 -0.01 (-0.50%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.00 +0.01 (+0.50%) As of 04/3/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV PharmaceuticalsMarket Capitalization$51.67 millionP/E Ratio-1.00Consensus RatingBuyConsensus Price Target$5.50 (+452.8% Upside)Volume105,975 sharesAverage Volume274,313 shares14. FibroBiologics NASDAQ:FBLG$0.88 -0.06 (-6.56%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.91 +0.04 (+4.46%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$31.86 millionConsensus RatingBuyConsensus Price Target$13.00 (+1,385.7% Upside)Volume197,192 sharesAverage Volume276,360 sharesToday's Range$0.87▼$0.9515. Invivyd NASDAQ:IVVD$0.55 -0.03 (-5.03%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.55 +0.00 (+0.55%) As of 06:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. More about InvivydMarket Capitalization$65.98 millionP/E Ratio-0.28Consensus RatingBuyConsensus Price Target$7.89 (+1,334.1% Upside)Volume1.71 million sharesAverage Volume4.22 million shares16. NRx Pharmaceuticals NASDAQ:NRXP$1.87 -0.14 (-6.97%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.88 +0.01 (+0.53%) As of 04/3/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx PharmaceuticalsMarket Capitalization$31.63 millionP/E Ratio-0.87Consensus RatingBuyConsensus Price Target$28.25 (+1,410.7% Upside)Volume170,640 sharesAverage Volume452,093 sharesRemove Ads17. Lucid Diagnostics NASDAQ:LUCD$1.50 +0.03 (+2.04%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.54 +0.04 (+2.93%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$136.13 millionP/E Ratio-1.32Consensus RatingBuyConsensus Price Target$3.40 (+126.7% Upside)Volume596,934 sharesAverage Volume366,368 shares18. HIVE Digital Technologies NASDAQ:HIVE$1.48 -0.13 (-8.07%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.49 +0.01 (+0.68%) As of 06:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital TechnologiesMarket Capitalization$243.59 millionP/E Ratio-29.60Consensus RatingBuyConsensus Price Target$7.64 (+416.4% Upside)Volume9.10 million sharesAverage Volume5.80 million shares19. Perspective Therapeutics NYSE:CATX$1.96 -0.09 (-4.39%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.94 -0.02 (-1.02%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective TherapeuticsMarket Capitalization$145.14 millionConsensus RatingBuyConsensus Price Target$14.44 (+637.0% Upside)Volume1.18 million sharesAverage Volume1.00 million sharesToday's Range$1.91▼$2.0420. Rani Therapeutics NASDAQ:RANI$1.30 -0.09 (-6.47%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.23 -0.08 (-5.77%) As of 05:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani TherapeuticsMarket Capitalization$74.48 millionP/E Ratio-1.23Consensus RatingBuyConsensus Price Target$12.33 (+848.7% Upside)Volume245,756 sharesAverage Volume745,808 shares21. ProQR Therapeutics NASDAQ:PRQR$1.27 -0.10 (-7.30%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.34 +0.06 (+5.12%) As of 04/3/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR TherapeuticsMarket Capitalization$144.14 millionP/E Ratio-3.97Consensus RatingBuyConsensus Price Target$9.50 (+648.0% Upside)Volume419,517 sharesAverage Volume568,965 shares22. Gain Therapeutics NASDAQ:GANX$1.79 -0.10 (-5.29%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.88 +0.09 (+5.25%) As of 04/3/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$47.48 millionP/E Ratio-1.63Consensus RatingBuyConsensus Price Target$8.20 (+358.1% Upside)Volume208,004 sharesAverage Volume283,675 shares23. Context Therapeutics NASDAQ:CNTX$0.72 +0.04 (+5.74%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$0.70 -0.02 (-3.20%) As of 05:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$64.50 millionP/E Ratio-0.79Consensus RatingBuyConsensus Price Target$6.17 (+757.7% Upside)Volume2.02 million sharesAverage Volume398,411 shares24. Aclaris Therapeutics NASDAQ:ACRS$1.49 -0.05 (-3.25%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.50 +0.01 (+0.34%) As of 04/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$160.80 millionP/E Ratio-2.87Consensus RatingBuyConsensus Price Target$11.67 (+683.0% Upside)Volume805,468 sharesAverage Volume1.17 million shares25. Compass Therapeutics NASDAQ:CMPX$1.60 -0.09 (-5.03%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$1.59 -0.01 (-0.93%) As of 05:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass TherapeuticsMarket Capitalization$221.94 millionP/E Ratio-4.34Consensus RatingBuyConsensus Price Target$11.63 (+624.3% Upside)Volume1.91 million sharesAverage Volume805,499 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum 5 Reasons Why Halliburton Is a Good Buy in 2025 First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock Tesla Stock: What To Expect With Their Delivery Numbers Report Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future Equinix: A Smart Bet on Data Centers, Dividends, and AI Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
